Search

Pencor

Pencor

doxazosin

Manufacturer:

Unison

Distributor:

Medispec
Concise Prescribing Info
Contents
Doxazosin mesylate
Indications/Uses
HTN & benign prostatic hyperplasia (BPH).
Click to view Pencor detailed prescribing information
Dosage/Direction for Use
HTN Initially 1 mg, may be increased if necessary. Max: 16 mg. BPH Initially 1 mg once daily. Recommended dose: 2-4 mg. Max: 8 mg.
Click to view Pencor detailed prescribing information
Overdosage
View Pencor overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to quinolones.
Click to view Pencor detailed prescribing information
Special Precautions
Postural hypotension/syncope; use w/ PDE-5 inhibitors; impaired liver function. Pregnancy & lactation.
Click to view Pencor detailed prescribing information
Adverse Reactions
Dizziness, vertigo, arrhythmias, dyspnea, orthostatic hypotension, priapism, headache, unusual tiredness, nausea & nervousness.
Drug Interactions
PDE-5 inhibitors.
Click to view Pencor detailed prescribing information
Storage
View Pencor storage conditions for details to ensure optimal shelf-life.
Description
View Pencor description for details of the chemical structure and excipients (inactive components).
Action
View Pencor mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Drugs for Bladder & Prostate Disorders / Other Antihypertensives
ATC Classification
C02CA04 - doxazosin ; Belongs to the class of alpha-adrenoreceptor antagonists, peripherally-acting antiadrenergic agents. Used in the treatment of hypertension.
Presentation/Packing
Form
Pencor tab 4 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in